MedPath

Improve Outcomes for Older Allogeneic Transplant Recipients

Not Applicable
Recruiting
Conditions
Allogeneic Transplantation
Interventions
Behavioral: Exercise Program (Cohort A Prehab)
Behavioral: Exercise Program (Cohort B Rehab)
Registration Number
NCT05612789
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
72
Inclusion Criteria

Cohort A (Prehab)

  1. Age 60 years or older.
  2. Planned allogeneic HCT in the next 1-6 months.
  3. Hematological malignancy as the indication for HCT.
  4. Pre-frail or frail by Fried frailty phenotype.

Cohort B (Rehab)

  1. Age 60 years or older.
  2. Planned allogeneic HCT or HCT within the last 30 days.
  3. Hematological malignancy as the indication for HCT.
Exclusion Criteria

Cohorts A and B

  1. Comorbid disability or illness that prevents safe exercise.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cohort A (Prehab)Exercise Program (Cohort A Prehab)Pre-frail and frail subjects will attend at least twice weekly exercise sessions with a physical therapist and be given an exercise program to complete at home prior to admission for HCT. Patients enrolled in this cohort can continue on to Cohort B.
Cohort B (Rehab)Exercise Program (Cohort B Rehab)All patients 60 years and older upon discharge from their initial hospital stay for HCT will attend at least weekly exercise sessions with a physical therapist and be given an exercise program to complete at home with sessions continued through Day +100 after HCT.
Primary Outcome Measures
NameTimeMethod
Proportion of enrolled subjects who participate in the supervised exercise programFrom 3 months prior to HCT to 100 days after HCT
Median number of exercise sessions delivered pre-HCT and post-HCT.From 3 months prior to HCT to 100 days after HCT
Secondary Outcome Measures
NameTimeMethod
1-year and 2-year PFSFrom day 0 of HCT to 1-year and 2-years
6-month and 1-year overall mortalityFrom day 0 of HCT to 6 months and 1-year] 6. 1-year and 2-year OS
Hospital LOS for HCTFrom date of randomization until the date of first documented discharge from the hospital, assessed up to 100 months
Rate of readmissionFrom time of discharge from initial hospital stay up through 1-2 years after HCT
1-year and 2-year OSFrom day 0 of HCT to 1-year and 2-years

Trial Locations

Locations (1)

Penn Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath